VirtualScopics, ABX-CRO collaborate on nuke med trials

VirtualScopics, a provider of quantitative imaging for clinical trials, has entered into a scientific collaboration, specific to molecular imaging, with ABX-CRO, a Dresden, Germany-based full-service contract research organization (CRO).

The partnership will provide pharmaceutical customers with an integrated service offering the combined knowledge and experience of both VirtualScopics and ABX-CRO in the area of functional imaging, especially, PET, SPECT and MRI, said the Rochester, N.Y.-based VirtualScopics.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.